| scholarly article | Q13442814 |
| P2093 | author name string | G M Goodwin | |
| Consensus Group of the British Association for Psychopharmacology | |||
| P2860 | cites work | Behavioral family treatment for patients with bipolar affective disorder | Q38004629 |
| Neuropsychological performance in pediatric bipolar disorder | Q39127586 | ||
| Neuropsychiatric adverse effects of antiparkinsonian drugs. Characteristics, evaluation and treatment | Q39456220 | ||
| Assessment of suicide risk | Q39668763 | ||
| The burden of care: the impact of functional psychiatric illness on the patient's family | Q39672916 | ||
| Diagnosis and classification of functional psychoses | Q39689391 | ||
| Secondary mania with focal cerebrovascular lesions | Q40220392 | ||
| Cost-effective screening for the metabolic syndrome in patients treated with second-generation antipsychotic medications | Q40417468 | ||
| Risk of puerperal and non-puerperal recurrence of illness following bipolar affective puerperal (post-partum) psychosis | Q40441971 | ||
| The co-occurrence of mania with medical and other psychiatric disorders | Q40517742 | ||
| Familiality of the puerperal trigger in bipolar disorder: results of a family study | Q40704858 | ||
| Oxcarbazepine: pharmacokinetic interactions and their clinical relevance | Q40739805 | ||
| Drug treatment of mania: a critical review | Q40850874 | ||
| Recent advances in geriatric psychopharmacology | Q40931095 | ||
| Cognitive therapy of affective disorders: a review. | Q40949754 | ||
| Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines | Q40979339 | ||
| Lithium use and discontinuation in a health maintenance organization | Q41014056 | ||
| Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials | Q42164457 | ||
| Bipolar affective disorder-left out in the cold. Too late for the national service framework but local initiatives may be possible | Q42751694 | ||
| Giving medicine a fair trial. Trials should not second guess what patients want | Q42786910 | ||
| Mood-stabilisers reduce the risk of developing antidepressant-induced maniform states in acute treatment of bipolar I depressed patients | Q43540822 | ||
| Repeated neural tube defects and valproate monotherapy suggest a pharmacogenetic abnormality | Q43650811 | ||
| Extending indications for long-term pharmacotherapy: opportunities and challenges | Q43843034 | ||
| Mood changes during prednisone bursts in outpatients with asthma | Q43859431 | ||
| Pattern of response to divalproex, lithium, or placebo in four naturalistic subtypes of mania | Q43942949 | ||
| Early physical and sexual abuse associated with an adverse course of bipolar illness | Q43962518 | ||
| Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety | Q44045819 | ||
| Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom's General Practice Rsearch Database | Q44299993 | ||
| The mood spectrum in unipolar and bipolar disorder: arguments for a unitary approach | Q44498201 | ||
| Olanzapine versus placebo in acute mania: treatment responses in subgroups | Q44550787 | ||
| A well-being programme in severe mental illness. Reducing risk for physical ill-health: a post-programme service evaluation at 2 years | Q44571078 | ||
| Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials | Q22241689 | ||
| Practice Parameter for the Assessment and Treatment of Children and Adolescents With Bipolar Disorder | Q22242775 | ||
| Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication | Q22253024 | ||
| Affective Disorders and Suicide Risk: A Reexamination | Q22306288 | ||
| Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis | Q24645193 | ||
| The longer term outcome of children born to mothers with epilepsy | Q24671544 | ||
| Suicide as an outcome for mental disorders. A meta-analysis | Q28244203 | ||
| National trends in the outpatient diagnosis and treatment of bipolar disorder in youth | Q28244462 | ||
| Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies | Q28247669 | ||
| Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial | Q28259736 | ||
| Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder | Q28270795 | ||
| Whole-genome association study of bipolar disorder | Q28271419 | ||
| Effectiveness of antipsychotic drugs in patients with chronic schizophrenia | Q28273164 | ||
| Childhood trauma, psychosis and schizophrenia: a literature review with theoretical and clinical implications | Q28276888 | ||
| Increased rates of bipolar disorder diagnoses among U.S. child, adolescent, and adult inpatients, 1996-2004 | Q28288705 | ||
| Effectiveness of adjunctive antidepressant treatment for bipolar depression | Q28295408 | ||
| The impact of substance abuse on the course of bipolar disorder | Q29306635 | ||
| Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations | Q29393835 | ||
| Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). | Q30977443 | ||
| Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: prospective data from phase 1 | Q31145823 | ||
| Reliability and validity of the DSM-IV diagnostic category of schizoaffective disorder: preliminary data | Q31565168 | ||
| Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia | Q31842937 | ||
| Acute bipolar mania: a systematic review and meta-analysis of co-therapy vs. monotherapy. | Q33268080 | ||
| Clinical guidelines: developing guidelines | Q33536430 | ||
| Use of psychotropic medications in breast-feeding women: acute and prophylactic treatment | Q33543077 | ||
| Interactions between anticonvulsant and psychoactive drugs | Q33803094 | ||
| The psychiatric side effects of corticosteroids | Q33808136 | ||
| Randomised controlled trial of efficacy of teaching patients with bipolar disorder to identify early symptoms of relapse and obtain treatment | Q37402290 | ||
| Spina bifida in infants of women treated with carbamazepine during pregnancy | Q37639771 | ||
| Exposure to case management: relationships to patient characteristics and outcome. Report from the UK700 trial. | Q51953611 | ||
| Suicide in psychiatric hospital in-patients. Risk factors and their predictive power. | Q51970579 | ||
| Validation of the prospective NIMH-Life-Chart Method (NIMH-LCM-p) for longitudinal assessment of bipolar illness. | Q51971858 | ||
| The history of electroconvulsive therapy in the United States and its place in American psychiatry: a personal memoir. | Q51984174 | ||
| An empirical comparison of diagnoses and reliabilities in ICD-10 and DSM-III-R. | Q52038795 | ||
| Predicting caregiver burden and depression in Alzheimer's disease. | Q52080728 | ||
| Are antidepressants less effective in the acute treatment of bipolar I compared to unipolar depression? | Q52937654 | ||
| The epidemiology of DSM-III-R bipolar I disorder in a general population survey. | Q53357821 | ||
| Recurrence of mania after lithium withdrawal. Implications for the use of lithium in the treatment of bipolar affective disorder. | Q54106227 | ||
| Status of bipolar disorder research. Bibliometric study. | Q54566212 | ||
| Mortality and causes of death in a total national sample of patients with affective disorders admitted for the first time between 1973 and 1993 | Q57517052 | ||
| A Randomized Trial on the Efficacy of Group Psychoeducation in the Prophylaxis of Recurrences in Bipolar Patients Whose Disease Is in Remission | Q57612892 | ||
| Suicide in Subtypes of Major Affective Disorder | Q57697323 | ||
| Cognitive vulnerability in patients with bipolar disorder | Q33902898 | ||
| Differential pharmacokinetics of lithium in elderly patients | Q33914223 | ||
| Historical perspectives and natural history of bipolar disorder | Q33920209 | ||
| A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders | Q33927263 | ||
| Impact of substance abuse on the course and treatment of bipolar disorder | Q33938089 | ||
| Have some guidelines for the treatment of acute bipolar depression gone too far in the restriction of antidepressants? | Q33942947 | ||
| Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis | Q33964983 | ||
| The long-term course of rapid-cycling bipolar disorder | Q33968228 | ||
| Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials | Q33975437 | ||
| Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. | Q33994367 | ||
| A history of investigation on the mood stabilizing effect of carbamazepine in Japan | Q34067077 | ||
| Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders | Q34106678 | ||
| Pharmacotherapy of depression and mixed states in bipolar disorder. | Q34106689 | ||
| Mania in neurologic disorders | Q34108544 | ||
| The comorbidity of bipolar and anxiety disorders: prevalence, psychobiology, and treatment issues | Q34116326 | ||
| A review of psychosocial outcome in patients with bipolar disorder | Q34176007 | ||
| Searching high and low: a review of the genetics of bipolar disorder | Q34186927 | ||
| Psychotherapy for bipolar depression: a phase-specific treatment strategy? | Q34188366 | ||
| Sleep reduction as a final common pathway in the genesis of mania | Q34191452 | ||
| Use of antipsychotic drugs and lithium in mania | Q34271244 | ||
| Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression | Q34275783 | ||
| Antidepressants for bipolar depression: a systematic review of randomized, controlled trials | Q34344394 | ||
| Polycystic ovarian syndrome in women with epilepsy: a review | Q34345051 | ||
| Lower suicide risk with long-term lithium treatment in major affective illness: a meta-analysis | Q34352552 | ||
| The Maudsley Bipolar Disorder Project: executive dysfunction in bipolar disorder I and its clinical correlates. | Q34436294 | ||
| Meta-analytical studies on new antidepressants. | Q34446903 | ||
| Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials | Q34456077 | ||
| Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group | Q34514128 | ||
| Current research on rapid cycling bipolar disorder and its treatment | Q34521351 | ||
| A randomized controlled study of cognitive therapy for relapse prevention for bipolar affective disorder: outcome of the first year | Q34531152 | ||
| Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management | Q34551484 | ||
| Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). | Q34564599 | ||
| A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents | Q34568810 | ||
| Labour and delivery complications at birth and later mania. An Irish case register study | Q44603068 | ||
| Double-blind comparison of the continued use of antipsychotic treatment versus its discontinuation in remitted manic patients | Q44710965 | ||
| Randomized trial of a population-based care program for people with bipolar disorder | Q44927545 | ||
| Controlled lithium discontinuation in bipolar patients with good response to long-term lithium prophylaxis | Q44945162 | ||
| Burden of general medical conditions among individuals with bipolar disorder | Q45070754 | ||
| Rates of lifetime suicide attempt and rates of lifetime major depression in different ethnic groups in the United States | Q45135411 | ||
| Efficacy of olanzapine combined with valproate or lithium in the treatment of dysphoric mania | Q45168960 | ||
| Prevalence of psychopathology in children of a bipolar parent. | Q45278571 | ||
| Decreased bone mineral density in male schizophrenia patients | Q45285645 | ||
| Clinically responsible genetic testing in neuropsychiatric patients: a bridge too far and too soon | Q45290333 | ||
| Newer antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparative studies | Q45293349 | ||
| Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group | Q45338046 | ||
| The long-term natural history of the weekly symptomatic status of bipolar I disorder | Q46317822 | ||
| Suicide: the leading cause of maternal death | Q46348293 | ||
| Lithium and eGFR: a new routinely available tool for the prevention of chronic kidney disease | Q46453133 | ||
| A long-term prospective study on the outcome of bipolar patients treated with long-acting injectable risperidone | Q46495720 | ||
| Family-focused treatment versus individual treatment for bipolar disorder: results of a randomized clinical trial. | Q46507616 | ||
| Neuropsychological task performance in bipolar spectrum illness: genetics, alcohol abuse, medication and childhood trauma | Q46614949 | ||
| A double-blind, randomized, placebo-controlled prophylaxis trial of oxcarbazepine as adjunctive treatment to lithium in the long-term treatment of bipolar I and II disorder | Q46697173 | ||
| Neonatal symptoms following maternal paroxetine treatment: serotonin toxicity or paroxetine discontinuation syndrome? | Q46705998 | ||
| Depot risperidone in the outpatient management of bipolar disorder: a 2-year study of 10 patients | Q46732807 | ||
| Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies | Q46801835 | ||
| Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine | Q46921511 | ||
| SSRIs as mood stabilizers for Bipolar II Disorder? A proof of concept study | Q46974782 | ||
| Efficacy and safety of aripiprazole in subpopulations with acute manic or mixed episodes of bipolar I disorder | Q46975571 | ||
| Extended-release carbamazepine capsules as monotherapy in bipolar disorder : pooled results from two randomised, double-blind, placebo-controlled trials | Q46984808 | ||
| Suicidal behavior in bipolar mood disorder: clinical characteristics of attempters and nonattempters | Q47347891 | ||
| Psychological predictors of weight regain in obesity. | Q47406591 | ||
| Bipolar disorder in the general population in The Netherlands (prevalence, consequences and care utilisation): results from The Netherlands Mental Health Survey and Incidence Study (NEMESIS). | Q47440847 | ||
| Maternal use of selective serotonin reuptake inhibitors and risk of congenital malformations | Q47855965 | ||
| Adverse subjective experience with antipsychotics and its relationship to striatal and extrastriatal D2 receptors: a PET study in schizophrenia | Q48220070 | ||
| Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study | Q48466826 | ||
| Sustained attention deficit in bipolar disorder | Q48643730 | ||
| Syndromes and phenomenological subtypes underlying acute mania: a factor analytic study of 576 manic patients | Q48660575 | ||
| Collaborative care for bipolar disorder: part I. Intervention and implementation in a randomized effectiveness trial. | Q50108135 | ||
| Recurrence in affective disorder. I. Case register study. | Q50897602 | ||
| Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline. | Q50929769 | ||
| Toward a re-definition of subthreshold bipolarity: epidemiology and proposed criteria for bipolar-II, minor bipolar disorders and hypomania. | Q51032804 | ||
| A prospective follow-up of patients with bipolar and primary unipolar affective disorder. | Q51053324 | ||
| Subtypes of mania determined by grade of membership analysis. | Q51063437 | ||
| The Northwick Park "functional" psychosis study: diagnosis and treatment response. | Q51186898 | ||
| Burden and marital and sexual satisfaction in the partners of bipolar patients. | Q51839813 | ||
| Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder. | Q51900824 | ||
| Risk of hip fracture in patients with a history of schizophrenia. | Q51907439 | ||
| New parents and mental disorders: a population-based register study. | Q51909269 | ||
| Descriptive and longitudinal observations on the relationship of borderline personality disorder and bipolar disorder. | Q51915349 | ||
| What really matters to bipolar patients' caregivers: sources of family burden. | Q51916677 | ||
| Long-term effectiveness and cost of a systematic care program for bipolar disorder. | Q51918257 | ||
| Cognitive-behavioural therapy for severe and recurrent bipolar disorders: randomised controlled trial. | Q51919569 | ||
| Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. | Q51943686 | ||
| Course and outcome of bipolar spectrum disorder in children and adolescents: a review of the existing literature | Q34576568 | ||
| Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a 9-month randomized controlled trial | Q34582156 | ||
| Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines | Q34590507 | ||
| Maternal use of antipsychotics in early pregnancy and delivery outcome. | Q34591997 | ||
| Treatment non-adherence in affective disorders. | Q34592227 | ||
| The genetic deconstruction of psychosis | Q34634774 | ||
| Prenatal and childhood influences on osteoporosis | Q34686168 | ||
| Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group | Q34727272 | ||
| Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use. | Q34735182 | ||
| Clinical course of children and adolescents with bipolar spectrum disorders | Q34814593 | ||
| Treatment of bipolar disorder in older adults | Q34832733 | ||
| Outcomes of prenatal antidepressant exposure | Q35008993 | ||
| Defining clinical phenotypes of juvenile mania | Q35075420 | ||
| Suicidal behaviour in bipolar disorder: risk and prevention | Q35129379 | ||
| Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology | Q35180787 | ||
| Neonatal hypoglycaemia and withdrawal symptoms after exposure in utero to valproate | Q35289892 | ||
| Contested boundaries of bipolar disorder and the limits of categorical diagnosis in psychiatry | Q35444572 | ||
| Antidepressants in bipolar disorder: the case for caution | Q35592492 | ||
| The effects of antipsychotic therapy on serum lipids: a comprehensive review. | Q35832656 | ||
| The impact of unrecognized bipolar disorders among patients treated for depression with antidepressants in the fee-for-services California Medicaid (Medi-Cal) program: a 6-year retrospective analysis. | Q36543681 | ||
| Cigarette smoking and overweight/obesity among individuals with serious mental illnesses: a preventive perspective | Q36567074 | ||
| Mood and anxiety spectrum as a means to identify clinically relevant subtypes of bipolar I disorder | Q36630380 | ||
| Pediatric bipolar disorder: validity, phenomenology, and recommendations for diagnosis | Q36693361 | ||
| The impact of gestational stress and prenatal growth on emotional problems in offspring: a review. | Q36736411 | ||
| Effect of prophylactic treatment on suicide risk in patients with major affective disorders. Data from a randomized prospective trial | Q36810994 | ||
| Deconstructing bipolar disorder: a critical review of its diagnostic validity and a proposal for DSM-V and ICD-11 | Q36847043 | ||
| Pharmacological interventions for acute bipolar mania: a systematic review of randomized placebo-controlled trials | Q36936379 | ||
| Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives. | Q36964951 | ||
| Family-focused treatment for adolescents with bipolar disorder: results of a 2-year randomized trial | Q37029242 | ||
| Augmentation of antidepressants with atypical antipsychotics for treatment-resistant major depressive disorder | Q37055322 | ||
| Electroconvulsive therapy in the treatment of mixed states in bipolar disorder | Q37055707 | ||
| Diagnostic guidelines for bipolar depression: a probabilistic approach | Q37058580 | ||
| Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia: a systematic review | Q37111491 | ||
| ECNP consensus meeting. Bipolar depression. Nice, March 2007. | Q37172336 | ||
| Do SSRIs or antidepressants in general increase suicidality? WPA Section on Pharmacopsychiatry: consensus statement | Q37230978 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bipolar disorder | Q131755 |
| P304 | page(s) | 346-388 | |
| P577 | publication date | 2009-03-27 | |
| P1433 | published in | Journal of Psychopharmacology | Q6295819 |
| P1476 | title | Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology | |
| P478 | volume | 23 |
| Q35965634 | A Systemic Review and Experts' Consensus for Long-acting Injectable Antipsychotics in Bipolar Disorder |
| Q38027197 | A UK panel consensus on the initiation of aripiprazole for the treatment of bipolar mania |
| Q36560064 | A critical review of the recent literature and selected therapy guidelines since 2006 on the use of lamotrigine in bipolar disorder |
| Q35038493 | A feasibility study of expert patient and community mental health team led bipolar psychoeducation groups: implementing an evidence based practice |
| Q48247071 | A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole for the treatment of acute manic or mixed episodes in Asian patients with bipolar I disorder (the AMAZE study). |
| Q34274031 | A systematic review on the role of anticonvulsants in the treatment of acute bipolar depression |
| Q33629104 | Acute renal failure induced by markedly decreased appetite secondary to a depressive episode after discontinuation of long-term lithium therapy in an elderly patient with bipolar disorder |
| Q24198987 | Adjunctive antioxidants for bipolar disorder |
| Q47294091 | An Oldie but Goodie: Lithium in the Treatment of Bipolar Disorder through Neuroprotective and Neurotrophic Mechanisms |
| Q38052088 | An update on antidepressant use in bipolar depression |
| Q38155979 | An updated review of the optimal lithium dosage regimen for renal protection |
| Q34154885 | Antidepressant treatment for acute bipolar depression: an update. |
| Q47285494 | Antidepressants and Mood Stabilizers: Novel Research Avenues and Clinical Insights for Bipolar Depression |
| Q28597251 | Applications of time-series analysis to mood fluctuations in bipolar disorder to promote treatment innovation: a case series. |
| Q24201765 | Aripiprazole alone or in combination for acute mania |
| Q57612470 | Aripiprazole in Bipolar Disorder |
| Q48258866 | Aripiprazole in combination with lamotrigine for the long-term treatment of patients with bipolar I disorder (manic or mixed): a randomized, multicenter, double-blind study (CN138-392). |
| Q28478032 | Aripiprazole in the maintenance treatment of bipolar disorder: a critical review of the evidence and its dissemination into the scientific literature |
| Q37970762 | Aripiprazole: a review of its use in the management of mania in adults with bipolar I disorder |
| Q38176566 | Aripiprazole: a review of its use in the treatment of manic episodes in adolescents with bipolar I disorder |
| Q36515504 | Asenapine in bipolar I disorder: evidence and place in patient management |
| Q34654574 | Assessing the roles of stimulants/stimulant-like drugs and dopamine-agonists in the treatment of bipolar depression |
| Q41633896 | Attitudes toward antipsychotic treatment among patients with bipolar disorders and their clinicians: a systematic review |
| Q34277168 | BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP. |
| Q45143440 | Basic presynaptic functions in hippocampal neurons are not affected by acute or chronic lithium treatment |
| Q38023889 | Beyond the guidelines for bipolar disorder: practical issues in long-term treatment with lithium. |
| Q39455953 | Bipolar affective disorder and Parkinson's disease |
| Q22252350 | Bipolar disorder |
| Q56039529 | Bipolar disorder |
| Q36389648 | Bipolar disorder dynamics: affective instabilities, relaxation oscillations and noise |
| Q42824178 | Bipolar spectrum disorders in primary care: optimising diagnosis and treatment |
| Q36799359 | Blood metabolomics analysis identifies abnormalities in the citric acid cycle, urea cycle, and amino acid metabolism in bipolar disorder |
| Q41387833 | Borderline personality disorder, but not euthymic bipolar disorder, is associated with a failure to sustain reciprocal cooperative behaviour: implications for spectrum models of mood disorders |
| Q26800235 | Bridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practice |
| Q34135759 | British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders. |
| Q41827832 | Bupropion Maintenance Treatment in Refractory Bipolar Depression: A Case Report |
| Q33661489 | Can Antipsychotic Agents be Considered as Real Antimanic Treatments? |
| Q39298349 | Carbamazepine directly inhibits adipocyte differentiation through activation of the ERK 1/2 pathway. |
| Q38556588 | Changing Trends in Treatment of Acute Mania: Experience of a Tertiary Centre Over a Decade |
| Q35044192 | Characteristics of bipolar disorder patients treated with immediate- and extended-release quetiapine in a real clinical setting: a longitudinal, cohort study of 1761 patients. |
| Q36600788 | Circadian Rhythm Characteristics in Mood Disorders: Comparison among Bipolar I Disorder, Bipolar II Disorder and Recurrent Major Depressive Disorder |
| Q35661570 | Circadian biomarkers in patients with bipolar disorder: promising putative predictors of lithium response |
| Q35667205 | Clinical Guidelines on Long-Term Pharmacotherapy for Bipolar Disorder in Children and Adolescents |
| Q37643038 | Clinical Practice Guidelines for Management of Bipolar Disorder |
| Q38097098 | Clinical assessment and crisis intervention for the suicidal bipolar disorder patient |
| Q38211511 | Clinical decision making in the treatment of mixed states |
| Q92403507 | Clozapine in Treatment-Resistant Bipolar Disorder With Suicidality. Three Case Reports |
| Q90477705 | Combination of Olanzapine and Samidorphan Has No Clinically Significant Effect on the Pharmacokinetics of Lithium or Valproate |
| Q34297422 | Combination of aripiprazole with mood stabilizers for the treatment of bipolar disorder: from acute mania to long-term maintenance |
| Q34308027 | Combination therapy for manic phases: a critical review of a common practice |
| Q34833550 | Comparably high retention and low relapse rates in different subpopulations of bipolar patients in a German non-interventional study |
| Q28245879 | Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis |
| Q22252432 | Comparative efficacy and acceptability of mood stabilizer and second generation antipsychotic monotherapy for acute mania — A systematic review and meta-analysis |
| Q34389967 | Compliance as a stable function in the treatment course of bipolar disorder in patients stabilized on olanzapine: results from a 24-month observational study |
| Q57048514 | Connectomics of bipolar disorder: a critical review, and evidence for dynamic instabilities within interoceptive networks |
| Q40659437 | Current prescription pattern of maintenance treatments for bipolar patients in Korea: A focus on the transition from acute treatments |
| Q35190057 | Customization in prescribing for bipolar disorder |
| Q36720064 | Cyclothymic disorder in youth: why is it overlooked, what do we know and where is the field headed? |
| Q22252261 | Cyclothymic disorder: A critical review |
| Q47593705 | DNA methylation signatures of mood stabilizers and antipsychotics in bipolar disorder |
| Q33442123 | Daily electronic monitoring of subjective and objective measures of illness activity in bipolar disorder using smartphones--the MONARCA II trial protocol: a randomized controlled single-blind parallel-group trial |
| Q35629112 | Delays before Diagnosis and Initiation of Treatment in Patients Presenting to Mental Health Services with Bipolar Disorder |
| Q34459114 | Diagnosis and treatment of bipolar disorders in adults: a review of the evidence on pharmacologic treatments |
| Q38586755 | Diagnosis, Epidemiology and Management of Mixed States in Bipolar Disorder |
| Q38297850 | Differential diagnosis of bipolar disorder and major depressive disorder |
| Q36388848 | Distinguishing between unipolar depression and bipolar depression: current and future clinical and neuroimaging perspectives |
| Q36374021 | Do antidepressants increase the risk of mania and bipolar disorder in people with depression? A retrospective electronic case register cohort study |
| Q38905720 | Do people with bipolar disorders have access to psychosocial treatments? A survey in Italy |
| Q54546967 | Do young adults with bipolar disorder benefit from early intervention? |
| Q41193666 | Drug information update. Lithium and chronic kidney disease: debates and dilemmas |
| Q43431795 | Duration of untreated bipolar disorder: missed opportunities on the long road to optimal treatment. |
| Q57834728 | Dépistage et prise en charge du trouble bipolaire : Résultats |
| Q36360718 | Early improvement of psychotic symptoms with lithium monotherapy as a predictor of later response in mania |
| Q47693761 | Early intervention for bipolar disorder in adolescents: A psychosocial perspective. |
| Q37979673 | Early intervention for bipolar disorder: current imperatives, future directions |
| Q36906936 | Effect of acute lithium administration on penile erection: involvement of nitric oxide system |
| Q35892866 | Effects of maintenance lithium treatment on serum parathyroid hormone and calcium levels: a retrospective longitudinal naturalistic study |
| Q28078078 | Efficacy and safety of second-generation antipsychotic long-acting injections (SGA LAIs) in maintenance treatment of bipolar disorder: protocol for a systematic review and meta-analysis |
| Q48310435 | Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study |
| Q38012647 | Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry |
| Q45822527 | Efficacy of psychoeducation on symptomatic and functional recovery in bipolar disorder |
| Q37424330 | Epidemiology, neurobiology and pharmacological interventions related to suicide deaths and suicide attempts in bipolar disorder: Part I of a report of the International Society for Bipolar Disorders Task Force on Suicide in Bipolar Disorder |
| Q34504406 | European Network of Bipolar Research Expert Centre (ENBREC): a network to foster research and promote innovative care |
| Q36588607 | Evidence review and clinical guidance for the use of ziprasidone in Canada |
| Q34676317 | Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology |
| Q38995982 | Experimental drugs for bipolar psychosis. |
| Q36140844 | Facilitated Integrated Mood Management for adults with bipolar disorder. |
| Q97517543 | Frequency-Specific Resting Connectome in Bipolar Disorder: An MEG Study |
| Q40041318 | Geographical disparities in prescription practices of lithium and clozapine: a community-based study |
| Q46300154 | Guidelines for the recognition and management of mixed depression |
| Q35073474 | Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illness |
| Q36568973 | How assess drugs in the treatment of acute bipolar mania? |
| Q37247922 | Impact of active monitoring on lithium management in Norfolk. |
| Q40267408 | Impact of natural lithium ressources on suicide mortality in Chile 2000-2009: a geographical analysis |
| Q38803931 | Improving classification of psychoses |
| Q36851161 | Innovative approaches to bipolar disorder and its treatment |
| Q33803579 | Investigation of the demographic characteristics and mental health in self-immolation attempters |
| Q43148709 | Is Valproate Depressogenic in Patients Remitting from Acute Mania? Case Series |
| Q33867761 | Is seasonal affective disorder a bipolar variant? |
| Q38068616 | Is there a clinical prodrome of bipolar disorder? A review of the evidence |
| Q39161964 | Is there consensus across international evidence-based guidelines for the management of bipolar disorder? |
| Q35142737 | Korean Medication Algorithm Project for Bipolar Disorder: third revision |
| Q35822006 | Korean Medication Algorithm for Bipolar Disorder 2014: comparisons with other treatment guidelines. |
| Q64078164 | Korean Medication Algorithm for Bipolar Disorder 2018: Comparisons with Other Treatment Guidelines |
| Q34515834 | LURASIDONE IN THE LONG-TERM TREATMENT OF PATIENTS WITH BIPOLAR DISORDER: A 24-WEEK OPEN-LABEL EXTENSION STUDY |
| Q57834706 | Les recommandations professionnelles dans le traitement de la dépression bipolaire |
| Q57831326 | Lithium and Circadian Rhythms |
| Q47875065 | Lithium and bipolar disorder: Impacts from molecular to behavioural circadian rhythms |
| Q34474219 | Lithium as add-on to quetiapine XR in adult patients with acute mania: a 6-week, multicenter, double-blind, randomized, placebo-controlled study |
| Q38695421 | Lithium dosing strategies during pregnancy and the postpartum period |
| Q38240532 | Lithium for bipolar disorder: a review of the recent literature |
| Q44973814 | Lithium in bipolar and other affective disorders: prescribing practice in the UK. |
| Q38676053 | Lithium in drinking water and the incidence of bipolar disorder: A nation-wide population-based study |
| Q34616063 | Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial |
| Q57471124 | Lithium, valproate, and carbamazepine prescribing patterns for long-term treatment of bipolar I and II disorders: A prospective study |
| Q37954426 | Lithium: still a major option in the management of bipolar disorder. |
| Q33885418 | Long-term response to mood stabilizer treatment and its clinical correlates in patients with bipolar disorders: a retrospective observational study |
| Q47623090 | Lurasidone: efficacy and safety in the treatment of psychotic and mood disorders |
| Q34268760 | Maintenance therapies in bipolar disorders |
| Q42603284 | Maintenance treatment with quetiapine when combined with either lithium or divalproex in bipolar I disorder: analysis of two large randomized, placebo-controlled trials |
| Q50070725 | Management of New Onset Psychosis in the Postpartum Period. |
| Q35365539 | Management of bipolar depression |
| Q38297863 | Managing the side effects associated with commonly used treatments for bipolar depression |
| Q34300315 | Mania: diagnosis and treatment recommendations |
| Q47618673 | Mental imagery and bipolar disorders: Introducing scope for psychological treatment development? |
| Q48939311 | Monitoring lithium therapy: the impact of a quality improvement programme in the UK. |
| Q30569917 | Mono- and combination drug therapies in hospitalized patients with bipolar depression. Data from the European drug surveillance program AMSP |
| Q35675661 | Mood instability is a common feature of mental health disorders and is associated with poor clinical outcomes |
| Q38243695 | Mood stabilizers and antipsychotics for acute mania: a systematic review and meta-analysis of combination/augmentation therapy versus monotherapy. |
| Q48008639 | NICE guidance: why not clozapine for treatment-refractory bipolar disorder? |
| Q39987572 | Nationwide and population-based prescription patterns in bipolar disorder |
| Q38736770 | Neuroprotective Effects of Açaí (Euterpe oleracea Mart.) against Rotenone In Vitro Exposure. |
| Q34476632 | One lithium level >1.0 mmol/L causes an acute decline in eGFR: findings from a retrospective analysis of a monitoring database. |
| Q45664480 | One-year rehospitalization rates of patients with first-episode bipolar mania receiving lithium or valproate and adjunctive atypical antipsychotics |
| Q37124973 | Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode: A CANMAT randomized double-blind trial. |
| Q29395337 | Options for Pharmacological Treatment of Refractory Bipolar Depression |
| Q37960632 | Oral ziprasidone in the treatment of patients with bipolar disorders: a critical review |
| Q38083305 | Overview of antidepressant treatment of bipolar depression |
| Q24234152 | Oxcarbazepine for acute affective episodes in bipolar disorder |
| Q42252223 | Patient perspectives on use of long-acting antipsychotics in bipolar disorder: focus on risperidone injection |
| Q45771100 | Patterns of pharmacological maintenance treatment in a community mental health services bipolar disorder cohort study (SIN-DEPRES). |
| Q34374891 | Pharmaco-utilisation and related costs of drugs used to treat schizophrenia and bipolar disorder in Italy: the IBIS study |
| Q34349641 | Pharmacological management of bipolar depression: acute treatment, maintenance, and prophylaxis |
| Q24198086 | Pharmacotherapy for bipolar disorder in older people |
| Q94400350 | Pharmacotherapy for bipolar disorder in older people |
| Q38364834 | Pharmacotherapy of acute mania: monotherapy or combination therapy with mood stabilizers and antipsychotics? |
| Q38143335 | Polypharmacy and bipolar disorder: what's personality got to do with it? |
| Q38336677 | Potential use of lurasidone for the treatment of bipolar psychosis |
| Q37908140 | Practical guidance for prescribing ziprasidone in acute manic or mixed episodes of bipolar I disorder |
| Q33967329 | Pragmatic randomised controlled trial of group psychoeducation versus group support in the maintenance of bipolar disorder |
| Q34579212 | Predominant polarity in bipolar disorder and validation of the polarity index in a German sample |
| Q34098311 | Prescribing trends in bipolar disorder: cohort study in the United Kingdom THIN primary care database 1995-2009. |
| Q49789172 | Proliferation and apoptosis of T lymphocytes in patients with bipolar disorder. |
| Q94560990 | Proteomic Profiling as a Diagnostic Biomarker for Discriminating Between Bipolar and Unipolar Depression |
| Q62274559 | Psycho- und soziotherapeutische Interventionen bei bipolaren affektiven Störungen: Review |
| Q38098608 | Purpose and effectiveness of psychoeducation in patients with bipolar disorder in a bipolar clinic setting |
| Q38237319 | Quetiapine extended release for the treatment of bipolar disorder |
| Q27499305 | Quetiapine monotherapy in bipolar II depression: combined data from four large, randomized studies |
| Q38132163 | Receptor mechanisms of antipsychotic drug action in bipolar disorder - focus on asenapine |
| Q43638820 | Recommendations for the treatment of mixed episodes in current guidelines |
| Q59341556 | Risk of manic switch with antidepressants use in patients with bipolar disorder in a Nigerian neuropsychiatric hospital |
| Q35862776 | Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders |
| Q38584632 | Safety and tolerability of anticonvulsant medication in bipolar disorder |
| Q38536939 | Safety and tolerability of antipsychotic-mood stabilizer co-treatment in the management of acute bipolar disorder: results from a systematic review and exploratory meta-analysis |
| Q26747614 | Self-limiting Atypical Antipsychotics-induced Edema: Clinical Cases and Systematic Review |
| Q33606886 | Self-poisoning suicide deaths in people with bipolar disorder: characterizing a subgroup and identifying treatment patterns. |
| Q26752539 | Significant Treatment Effect of Bupropion in Patients With Bipolar Disorder but Similar Phase-Shifting Rate as Other Antidepressants: A Meta-Analysis Following the PRISMA Guidelines |
| Q38433416 | Substantial changes in prescription recommendations for bipolar disorder in Canada: 2002-2010. |
| Q38084340 | Suicide in prisoners with bipolar disorder and other psychiatric disorders: a systematic review. |
| Q35129198 | Suicide risk in Veterans Health Administration patients with mental health diagnoses initiating lithium or valproate: a historical prospective cohort study |
| Q47551095 | The Camden & Islington Research Database: Using electronic mental health records for research |
| Q28066714 | The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm |
| Q28069743 | The International College of Neuro-Psychopharmacology (CINP) treatment guidelines for Bipolar disorder in adults (CINP-BD-2017), part 3: The clinical guidelines |
| Q30583384 | The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders |
| Q41638870 | The Role of Electroconvulsive Therapy (ECT) in Bipolar Disorder: Effectiveness in 522 Patients with Bipolar Depression, Mixed-state, Mania and Catatonic Features |
| Q34649187 | The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder |
| Q35559908 | The clinical management of bipolar disorder: a review of evidence-based guidelines |
| Q36132270 | The clinical significance of creativity in bipolar disorder |
| Q38648192 | The continuum of unipolar depression − bipolar II depression - bipolar I depression: different treatments indicated? |
| Q22241708 | The course of bipolar disorder |
| Q38208032 | The effectiveness of lurasidone as an adjunct to lithium or divalproex in the treatment of bipolar disorder |
| Q47389328 | The effects of medication and current mood upon facial emotion recognition: findings from a large bipolar disorder cohort study. |
| Q36784587 | The increasing frequency of mania and bipolar disorder: causes and potential negative impacts. |
| Q33838110 | The influence of psychoeducation on regulating biological rhythm in a sample of patients with bipolar II disorder: a randomized clinical trial |
| Q38767618 | The management of bipolar disorder |
| Q37881968 | Therapeutic options in treatment-resistant depression |
| Q24234313 | Tiagabine in the maintenance treatment of bipolar disorder |
| Q45772880 | Treatment guidelines for acute mania |
| Q44724569 | Treatment in a specialised out-patient mood disorder clinic v. standard out-patient treatment in the early course of bipolar disorder: randomised clinical trial |
| Q39287194 | Treatment of Bipolar Disorder in a Lifetime Perspective: Is Lithium Still the Best Choice? |
| Q57730484 | Treatment of bipolar depression |
| Q28290437 | Treatment of bipolar disorder |
| Q34823805 | Treatment of bipolar disorders during pregnancy: maternal and fetal safety and challenges |
| Q38003198 | Treatment options for acute depression in bipolar disorder |
| Q48135219 | Trends in the psychopharmacological treatment of bipolar disorder: a nationwide register-based study. |
| Q37006387 | Trends in the use of antipsychotics in the Israeli inpatient population, 2004-2013. |
| Q46814329 | Trends in the utilisation of psychotropic medications in Australia from 2000 to 2011. |
| Q87815172 | Two years' outcome of acute mania in bipolar disorder: different effects of age and age of onset |
| Q36491106 | Unrecognised bipolar disorder among UK primary care patients prescribed antidepressants: an observational study |
| Q36393992 | Update on extended release quetiapine fumarate in schizophrenia and bipolar disorders |
| Q38093728 | Use of asenapine in clinical practice for the management of bipolar mania |
| Q37918851 | Use of lithium in the treatment of bipolar disorder in late-life |
| Q37453882 | Use of mental health services in transition age youth with bipolar disorder |
| Q59103349 | Valproate Prescribing in Women of Childbearing Age: An Audit of Clinical Practice |
| Q34264093 | Valproate in acute mania: is our practice evidence based? |
| Q97549114 | Valproate inhibits mitochondrial bioenergetics and increases glycolysis in Saccharomyces cerevisiae |
| Q53109252 | Valproate prescriptions for nonepilepsy disorders in reproductive-age women. |
| Q24203023 | Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder |
| Q27014860 | When to start aripiprazole therapy in patients with bipolar mania |
| Q37272654 | White matter alterations in antipsychotic- and mood stabilizer-naïve individuals with bipolar II/NOS disorder |
| Q83164788 | [Antidepressants in bipolar disorder] |
| Q84842791 | [Are atypical antipsychotic drugs the first line treatment for bipolar disorders? For] |
| Q22252370 | ‘Bipolar disorder’ in the elderly: What's in a name? |
Search more.